107 results
ACC/AHA 2018 Cholesterol Guideline Algorithm for Secondary Prevention

#Cholesterol #Guidelines #Algorithm #ACCAHA #2018 #Cardiology #Statins #PCSK9
ACC/AHA 2018 Cholesterol ... Guideline Algorithm ... #Cholesterol #Guidelines ... #Algorithm #ACCAHA ... #2018 #Cardiology
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Update of the 2013 ... ACCF/AHA Guideline ... Management #CHF #guideline ... cardiology #treatment #algorithm
ACC/AHA Statin Guidelines - 2013 vs 2017

In 2013 the ACC/AHA guidelines drastically changed the way we
ACC/AHA Statin Guidelines ... - 2013 vs 2017 ... /AHA guidelines ... Guidelines #PrimaryCare ... #Goals #Comparison
How does the 2019 Novel Coronavirus (nCoV2019) compare to Ebola, SARS, MERS? Cases and Deaths
Weighing diseases
case-fatality remains stable ... Congo, Uganda: (2018 ... MERS coronavirus (2012 ... nCoV (December 2019 ... #Coronavirus #comparison
Algorithm for Management of the Overweight/Obese Patient - AACE 2018 Guidelines

#Obese #Obesity #AACE #2018 #Guidelines #Algorithm
Algorithm for Management ... Patient - AACE 2018 ... Guidelines #Obese ... Obesity #AACE #2018 ... #Guidelines #Algorithm
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... Medications approved ... WeightLoss #AACE #2016 ... #Pharmacology #Table ... #Comparison
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_/

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Pnuemonia Management Algorithm ... - IDSA 2019 Guidelines ... Pneumonia #Management #Algorithm ... #IDSA2019 #Guidelines
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Pnuemonia Management Algorithm ... - IDSA 2019 Guidelines ... Pneumonia #Management #Algorithm ... #IDSA2019 #Guidelines
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... #Antidiabetic #Medications ... #SideEffects #Table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Inhibitor GOLD 2019 ... Dosing: 250 mcg tablet ... GOLD guidelines ... #Roflumilast #Indications